Related Experiment Video
Updated: May 19, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Multimodal Remote Digital Phenotyping for Detecting and Tracking Early Parkinsonian Change in LRRK2 Carriers
T M Tariq Adnan1,2, Abdelrahman Abdelkader1, Md Saiful Islam1
1Department of Computer Science, University of Rochester, Rochester, New York, United States.
Research Square
|May 18, 2026
Summary
This study introduces an AI-powered video analysis tool to detect early Parkinson's disease (PD) in LRRK2 gene carriers. The framework accurately identifies high-risk individuals before clinical diagnosis and monitors disease progression.
Area of Science:
- Neuroscience
- Genetics
- Artificial Intelligence
Background:
- Identifying prodromal Parkinson's disease (PD) in individuals carrying LRRK2 mutations is crucial for early intervention but remains challenging.
- LRRK2 gene mutations are a significant genetic factor in Parkinson's disease, necessitating focused research on carriers.
Purpose of the Study:
- To develop and validate a remote, multimodal video analysis framework for early PD detection in LRRK2 carriers.
- To distinguish between non-manifest LRRK2 carriers and healthy controls, and to monitor early clinical changes indicative of PD onset.
Main Methods:
- Analysis of video data from 829 participants, including 158 LRRK2 carriers (36 with manifest PD, 122 non-manifest) and controls.
- Development of an AI model for classification and a continuous score ('PD Weigh-In') for monitoring disease progression.
- Validation of the AI model's accuracy and correlation of the 'PD Weigh-In' score with expert clinical ratings.
Main Results:
- The AI model achieved 92.9% accuracy in distinguishing non-manifest LRRK2 carriers from controls (AUROC 0.92, AUPRC 0.82).
- The 'PD Weigh-In' score effectively captured clinical decline in carriers who later developed PD.
- The score demonstrated strong correlation with expert assessments (Pearson r = 0.77, Spearman ρ = 0.79) in the LRRK2 test cohort.
Conclusions:
- A remote, AI-driven video analysis framework can effectively identify individuals at high risk for Parkinson's disease among LRRK2 carriers.
- This technology holds promise for early detection and continuous monitoring of prodromal Parkinson's disease, facilitating timely therapeutic strategies.
More Related Videos
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

